Zhou Zhang

Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

A multi-stage validation of the C-reactive protein-triglyceride-glucose index for predicting mild cognitive impairment: evidence from clinical and nationwide prospective cohorts.

A multi-stage validation of the C-reactive protein-triglyceride-glucose index for predicting mild cognitive impairment: evidence from clinical and nationwide prospective cohorts.

Journal: Frontiers in endocrinology

Published: March 28, 2026

Associations of Visceral Obesity Indices and Risk of Mild Cognitive Impairment in Patients With Diabetes: A Retrospective Cohort Study.

Associations of Visceral Obesity Indices and Risk of Mild Cognitive Impairment in Patients With Diabetes: A Retrospective Cohort Study.

Journal: Diabetes, obesity & metabolism

Published: January 29, 2026

Dementia Burden and Modifiable Risk Factors in Type 2 Diabetes: Population Based, Prospective Cohort Study.

Dementia Burden and Modifiable Risk Factors in Type 2 Diabetes: Population Based, Prospective Cohort Study.

Journal: Diabetes, obesity & metabolism

Published: December 18, 2025

Evaluating the effects of liraglutide, empagliflozin and linagliptin on mild cognitive impairment remission in patients with type 2 diabetes (LIGHT-MCI): study protocol for a multicentre, randomised controlled trial with an extension phase.

Evaluating the effects of liraglutide, empagliflozin and linagliptin on mild cognitive impairment remission in patients with type 2 diabetes (LIGHT-MCI): study protocol for a multicentre, randomised controlled trial with an extension phase.

Journal: BMJ open

Published: August 21, 2025

Henagliflozin enhances frontal neural activation and cognitive function versus gliclazide in type 2 diabetes patients with mild cognitive impairment: A 16-week randomized controlled trial.

Henagliflozin enhances frontal neural activation and cognitive function versus gliclazide in type 2 diabetes patients with mild cognitive impairment: A 16-week randomized controlled trial.

Journal: Journal of endocrinological investigation

Published: August 20, 2025

Sensory network dysregulation in type 2 diabetes: Linking olfactory, visual, and cognitive function.

Sensory network dysregulation in type 2 diabetes: Linking olfactory, visual, and cognitive function.

Journal: Diabetes, obesity & metabolism

Published: August 03, 2025

Olfactory training improves cognition and modifies brain networks in type 2 diabetes patients with mild cognitive impairment: A 16-week randomised controlled trial.

Olfactory training improves cognition and modifies brain networks in type 2 diabetes patients with mild cognitive impairment: A 16-week randomised controlled trial.

Journal: Diabetes, obesity & metabolism

Published: July 24, 2025

Impact of serum prolactin on cognitive function, brain structure, and function in type 2 diabetes mellitus.

Impact of serum prolactin on cognitive function, brain structure, and function in type 2 diabetes mellitus.

Journal: The Journal of clinical endocrinology and metabolism

Published: July 20, 2025

Dapagliflozin restores odour-induced functional integration of primary olfactory cortex circuit but not olfactory-related regional brain activation in patients with type 2 diabetes: A 16-week randomised comparative study.

Dapagliflozin restores odour-induced functional integration of primary olfactory cortex circuit but not olfactory-related regional brain activation in patients with type 2 diabetes: A 16-week randomised comparative study.

Journal: Diabetes, obesity & metabolism

Published: June 09, 2025

Non-alcoholic fatty liver disease is associated with structural covariance network reconfiguration in cognitively unimpaired adults with type 2 diabetes.

Non-alcoholic fatty liver disease is associated with structural covariance network reconfiguration in cognitively unimpaired adults with type 2 diabetes.

Journal: Neuroscience

Published: December 10, 2024

Prolactin deficiency drives diabetes-associated cognitive dysfunction by inducing microglia-mediated synaptic loss.

Prolactin deficiency drives diabetes-associated cognitive dysfunction by inducing microglia-mediated synaptic loss.

Journal: Journal of neuroinflammation

Published: September 18, 2024

Identification of adipose tissue-derived exosomal microRNA as a novel causal biomarker for cognitive impairment in type 2 diabetes mellitus: Triangulating evidence from Mendelian randomization and multicentre population studies.

Identification of adipose tissue-derived exosomal microRNA as a novel causal biomarker for cognitive impairment in type 2 diabetes mellitus: Triangulating evidence from Mendelian randomization and multicentre population studies.

Journal: Diabetes, obesity & metabolism

Published: September 05, 2024

Showing 1-12 of 21

Last Updated: 09/26/2026